Bedrock Data | $25,000,000 | (Nov 20, 2025)
Mangusta Capital | $25,000,000 | (Nov 20, 2025)
Method Security | $26,000,000 | (Nov 20, 2025)
Generare
France
- Paris, Île-de-France
- 08/10/2024
- Seed
- $5,495,250
Natural products have contributed more than 500 molecules to pharmaceuticals.
However, conventional methods for discovering new natural products are increasingly ineffective.
Generare has developed a revolutionary platform that identifies and expresses a wide range of naturally occurring secondary metabolites, selected by millions of years of bacterial evolution.
This platform allows us to reintroduce these lead molecules into clinical pipelines, reopening a validated avenue for therapeutic innovation.
- Industry Biotechnology Research
- Website https://generare.bio/
- LinkedIn https://www.linkedin.com/company/generare-bioscience/
Related People
Guillaume VandeneschFounder
France -
Paris, Île-de-France
Biotech Engineer with 10+ years exp in innovation & and consulting.
- Successful exit Possible Future 2022 to Capgemini Invent
Launched Generare in March 23' to revolutionize early drug discovery
Generare is a data-driven discovery platform that will revive the field of natural products, bringing this historically successful modality into the clinical pipelines.
Our POC in Nat Coms by Dr. Vincent Libis : http://bit.ly/3RL6JPL
Underlying tech awarded with ERC Starting Grant
More info about Generare available at https://docsend.com/view/dvwzjcj6n4vx36y9
Modern Life | $20,000,000 | (Nov 20, 2025)
Manta Cares | $5,400,000 | (Nov 20, 2025)
Jiga | $12,000,000 | (Nov 20, 2025)
alphaXiv | $7,000,000 | (Nov 20, 2025)
Kaaj | $3,800,000 | (Nov 20, 2025)
Synthio Labs | $5,000,000 | (Nov 20, 2025)
Freya (YC S25) | $3,500,000 | (Nov 20, 2025)
Amperesand | $80,000,000 | (Nov 20, 2025)
Ember(US) | $4,300,000 | (Nov 20, 2025)
OpenHands | $18,800,000 | (Nov 20, 2025)